Immunotherapy duo takes on rare cancers: hope for patients with few options
NCT ID NCT04969887
First seen Feb 28, 2026 · Last updated May 16, 2026 · Updated 9 times
Summary
This study tests a combination of two immunotherapy drugs, ipilimumab and nivolumab, in people with rare cancers that are known to respond to immunotherapy. The cancers include certain neuroendocrine tumors, biliary tract cancers, gynecological cancers, and mismatch repair deficient (MSI-H) tumors. The goal is to see if this treatment can shrink tumors or slow cancer growth. About 240 participants will receive the drug combination and be monitored for response and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Auckland City Hospital
Auckland, New Zealand
-
Austin Health
Heidelberg, Victoria, 3084, Australia
-
Barwon Health
Geelong, Victoria, Australia
-
Bendigo Health Services
Bendigo, Victoria, Australia
-
Blacktown Hospital
Sydney, New South Wales, 2145, Australia
-
Border Medical Oncology Unit
Albury, New South Wales, 2640, Australia
-
Cairns and Hinterland Hospital and Health Service
Cairns, Queensland, 4870, Australia
-
Calvary Mater Newcastle
Waratah, New South Wales, 2298, Australia
-
Fiona Stanley Hospital
Perth, Western Australia, Australia
-
Goulburn Valley Health
Shepparton, Victoria, 3630, Australia
-
Orange Health Service
Orange, New South Wales, Australia
-
Peninsula Health
Frankston, Victoria, Australia
-
Peter MacCalllum Cancer Centre
Parkville, Victoria, Australia
-
Royal Adelaide Hospital
Adelaide, South Australia, Australia
-
Royal Hobart Hospital
Hobart, Tasmania, 7000, Australia
-
South West Healthcare
Warrnambool, Victoria, Australia
-
Townsville Hospital and Health Service
Douglas, Queensland, 4814, Australia
-
Townville Hospital and Health Service
Townsville, Queensland, 4814, Australia
Conditions
Explore the condition pages connected to this study.